H1B Salary Data

Home › Employers › Bansi Pharmacy Inc

Bansi Pharmacy Inc: H-1B salaries and sponsorship

Bansi Pharmacy Inc filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $105,165.

Applications (LCAs)3
Certified3
Employer addressManalapan, NJ
H-1B dependent employerNo
Median offered salary$105,165
Middle half of salaries$105,165–$105,165
10th–90th percentile$105,165–$105,165

Does Bansi Pharmacy Inc sponsor H-1B visas?

Bansi Pharmacy Inc filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on May 1, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Regulatory & Compliance Analyst2$105,165
Regulatory and Compliance Analyst1—

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20232$105,165
FY20261—

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Regulatory and Compliance Analyst$130,000
part-time · Level IV
Manalapan, NJMay 1, 2026Oct 31, 2026Certified
Regulatory & Compliance Analyst$105,165
part-time · Level III
Manalapan Township, NJJul 6, 2023Nov 1, 2023Certified
Regulatory & Compliance Analyst$105,165
Level III
Manalapan Township, NJJul 5, 2023Nov 1, 2023Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).